CharlieKey takeaways from your favorite podcasts
← 1 October 2026Sourcery with Molly O'Shea

Annie Lamont: $14B Managed, 70+ Exits, 15 IPOs, 7x Midas Investor

Annie Lamont argues AI has reached the point of real impact in drug discovery and healthcare, that founder quality and defensibility matter more than hype, and that most inflated AI valuations won't hold.

Watch on YouTube ↗

No quote from this episode passed Charlie's judge.

Do more with Charlie

Free — sign in with your email, no password.